Financhill
Sell
48

CI Quote, Financials, Valuation and Earnings

Last price:
$333.59
Seasonality move :
1.66%
Day range:
$331.94 - $337.00
52-week range:
$262.03 - $370.83
Dividend yield:
1.72%
P/E ratio:
18.44x
P/S ratio:
0.36x
P/B ratio:
2.23x
Volume:
1.5M
Avg. volume:
1.8M
1-year change:
-2.51%
Market cap:
$89.8B
Revenue:
$244.4B
EPS (TTM):
$18.06
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $160.6B $174.3B $180B $195.2B $244.4B
Revenue Growth (YoY) 4.43% 8.54% 3.31% 8.42% 25.21%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.1B $13B $13.2B $14.8B $14.8B
Other Inc / (Exp) $107.8B $121.4B $128.6B $137.2B $185.4B
Operating Expenses $123.5B $132.4B $141.5B $148.9B $199.1B
Operating Income -- -- -- -- --
 
Net Interest Expenses $1.4B $1.2B $1.2B $1.4B $1.4B
EBT. Incl. Unusual Items $10.9B $6.8B $8.4B $5.5B $5.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.4B $1.4B $1.6B $141M $1.5B
Net Income to Company $8.5B $5.4B $6.8B $5.4B $3.8B
 
Minority Interest in Earnings -$31M -$50M -$78M -$208M -$344M
Net Income to Common Excl Extra Items $8.5B $5.4B $6.7B $5.2B $3.4B
 
Basic EPS (Cont. Ops) $23.17 $15.89 $21.66 $17.57 $12.25
Diluted EPS (Cont. Ops) $22.96 $15.75 $21.41 $17.39 $12.12
Weighted Average Basic Share $365M $338M $309.5M $293.9M $280.3M
Weighted Average Diluted Share $368.4M $341M $313.1M $296.9M $283.2M
 
EBITDA -- -- -- -- --
EBIT $12.3B $8B $9.6B $7B $6.7B
 
Revenue (Reported) $160.6B $174.3B $180B $195.2B $244.4B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $12.3B $8B $9.6B $7B $6.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $41B $43.7B $46.5B $55.4B $65.5B
Revenue Growth (YoY) 6.75% 6.62% 6.36% 19.28% 18.19%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3B $3.3B $3.5B $3.7B $4.2B
Other Inc / (Exp) $28B $30.7B $32.1B $42B $48.6B
Operating Expenses $30.9B $33.5B $35.5B $45.5B $53.1B
Operating Income -- -- -- -- --
 
Net Interest Expenses $314M $299M $358M $322M $362M
EBT. Incl. Unusual Items $1.5B $1.6B $1.6B $79M $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $342M $355M $295M $291M $239M
Net Income to Company $1.2B $1.2B $1.3B -$212M $1.4B
 
Minority Interest in Earnings -$10M -$15M -$39M -$65M -$86M
Net Income to Common Excl Extra Items $1.2B $1.2B $1.3B -$277M $1.3B
 
Basic EPS (Cont. Ops) $3.33 $3.76 $4.28 -$0.97 $4.88
Diluted EPS (Cont. Ops) $3.30 $3.73 $4.24 -$0.97 $4.85
Weighted Average Basic Share $348.2M $318.5M $295.7M $286.5M $270.9M
Weighted Average Diluted Share $352M $321.3M $299M $286.5M $270.9M
 
EBITDA -- -- -- -- --
EBIT $1.8B $1.9B $2B $401M $2B
 
Revenue (Reported) $41B $43.7B $46.5B $55.4B $65.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $1.8B $1.9B $2B $401M $2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $163.1B $177B $182.8B $204.1B $254.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14B $13B $13.4B $15B $15.4B
Other Inc / (Exp) $110.7B $124.1B $130B $147.1B $192B
Operating Expenses $126.5B $135.1B $143.5B $159B $206.6B
Operating Income -- -- -- -- --
 
Net Interest Expenses $1.4B $1.2B $1.3B $1.4B $1.5B
EBT. Incl. Unusual Items $11B $6.8B $8.4B $4B $6.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.5B $1.4B $1.6B $137M $1.4B
Net Income to Company $8.5B $5.5B $6.9B $3.9B $5.4B
 
Minority Interest in Earnings -$33M -$55M -$102M -$234M -$365M
Net Income to Common Excl Extra Items $8.4B $5.4B $6.8B $3.6B $5B
 
Basic EPS (Cont. Ops) $23.31 $16.35 $22.12 $12.27 $18.17
Diluted EPS (Cont. Ops) $23.11 $16.21 $21.93 $12.18 $18.06
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $12.3B $8B $9.7B $5.4B $8.3B
 
Revenue (Reported) $163.1B $177B $182.8B $204.1B $254.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $12.3B $8B $9.7B $5.4B $8.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $41B $43.7B $46.5B $55.4B $65.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3B $3.3B $3.5B $3.7B $4.2B
Other Inc / (Exp) $28B $30.7B $32.1B $42B $48.6B
Operating Expenses $30.9B $33.5B $35.5B $45.5B $53.1B
Operating Income -- -- -- -- --
 
Net Interest Expenses $314M $299M $358M $322M $362M
EBT. Incl. Unusual Items $1.5B $1.6B $1.6B $79M $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $342M $355M $295M $291M $239M
Net Income to Company $1.2B $1.2B $1.3B -$212M $1.4B
 
Minority Interest in Earnings -$10M -$15M -$39M -$65M -$86M
Net Income to Common Excl Extra Items $1.2B $1.2B $1.3B -$277M $1.3B
 
Basic EPS (Cont. Ops) $3.33 $3.76 $4.28 -$0.97 $4.88
Diluted EPS (Cont. Ops) $3.30 $3.73 $4.24 -$0.97 $4.85
Weighted Average Basic Share $348.2M $318.5M $295.7M $286.5M $270.9M
Weighted Average Diluted Share $352M $321.3M $299M $286.5M $270.9M
 
EBITDA -- -- -- -- --
EBIT $1.8B $1.9B $2B $401M $2B
 
Revenue (Reported) $41B $43.7B $46.5B $55.4B $65.5B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $1.8B $1.9B $2B $401M $2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $10.2B $5.1B $5.9B $7.8B $7.6B
Short Term Investments $1.3B $920M $905M $925M $665M
Accounts Receivable, Net $17.2B $19.6B $22.4B $23.4B $30.4B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $28.9B $26.1B $29.5B $32.4B $38.7B
 
Property Plant And Equipment $4.2B $4B $3.8B $3.9B $4B
Long-Term Investments $1.3B $920M $905M $925M $665M
Goodwill $44.6B $45.8B $45.8B $44.3B $44.4B
Other Intangibles $35.2B $34.2B $32.5B $30.9B $29.4B
Other Long-Term Assets -- -- -- -- --
Total Assets $155.5B $154.9B $143.9B $152.8B $155.9B
 
Accounts Payable $5.5B $6.7B $7.8B $8.6B $9.3B
Accrued Expenses $8.5B $7.3B $8B $10B $9.4B
Current Portion Of Long-Term Debt $18M $23M $33M $42M $43M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $30.7B $31.8B $35.8B $41.1B $50.2B
 
Long-Term Debt $29.5B $31.1B $28.1B $28.2B $28.9B
Capital Leases -- -- -- -- --
Total Liabilities $105.1B $107.7B $99.1B $106.4B $114.6B
 
Common Stock $4M $4M $4M $4M $4M
Other Common Equity Adj -$861M -$884M -$1.7B -$1.9B -$2.3B
Common Equity $50.3B $47.1B $44.7B $46.2B $41B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $65M $72M $79M $128M $210M
Total Equity $50.4B $47.2B $44.8B $46.4B $41.2B
 
Total Liabilities and Equity $155.5B $154.9B $143.9B $152.8B $155.9B
Cash and Short Terms $11.5B $6B $6.8B $8.7B $8.2B
Total Debt $32.9B $33.7B $31.1B $30.9B $32B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $6.5B $4.4B $7.9B $8.4B $8.3B
Short Term Investments $1.5B $731M $914M $1.1B $727M
Accounts Receivable, Net $18.6B $20.6B $22.7B $25.2B $31.3B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $26.7B $26.1B $31.8B $34.8B $40.4B
 
Property Plant And Equipment $4.1B $3.7B $3.8B $3.6B $3.7B
Long-Term Investments $1.5B $731M $914M $1.1B $727M
Goodwill $44.6B $45.8B $45.8B $44.3B $44.4B
Other Intangibles $34.8B $33.7B $32.1B $30.5B $29B
Other Long-Term Assets -- -- -- -- --
Total Assets $152.1B $152.6B $148B $153.1B $150.7B
 
Accounts Payable $19.4B $21.9B $7.4B $8.1B $9.1B
Accrued Expenses $7.9B $7.8B $9.2B $8.9B $8B
Current Portion Of Long-Term Debt $20M $27M $36M $42M $4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $27.7B $31.9B $37.6B $43B $49.8B
 
Long-Term Debt $31.6B $31B $29.1B $31.1B $26.5B
Capital Leases -- -- -- -- --
Total Liabilities $103.9B $106.4B $103.4B $111.8B $110.2B
 
Common Stock $4M $4M $4M $4M $4M
Other Common Equity Adj -$1.2B -$1.5B -$1.8B -$2.3B -$2.6B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $65M $77M $94M $169M $188M
Total Equity $48.2B $46.2B $44.6B $41.4B $40.4B
 
Total Liabilities and Equity $152.1B $152.6B $148B $153.1B $150.7B
Cash and Short Terms $8B $5.2B $8.8B $9.5B $9.1B
Total Debt $32B $33.2B $32.5B $32.8B $30.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $8.5B $5.4B $6.8B $5.4B $3.8B
Depreciation & Amoritzation $2.8B $2.9B $2.9B $3B $2.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.6B -$3.5B -$1.8B -$2.2B -$7.9B
Change in Inventories -- -- -- -- --
Cash From Operations $10.4B $7.2B $8.7B $11.8B $10.4B
 
Capital Expenditures $1.1B $1.2B $1.3B $1.6B $1.4B
Cash Acquisitions $5.5B -$1.9B $4.8B -$434M $390M
Cash From Investing $3B -$3.6B $3.1B -$5.2B -$2.1B
 
Dividends Paid (Ex Special Dividend) -$15M -$1.3B -$1.4B -$1.5B -$1.6B
Special Dividend Paid
Long-Term Debt Issued $4.9B $4.3B -- $1.5B $4.5B
Long-Term Debt Repaid -$9.4B -$4.6B -$500M -$3B -$3B
Repurchase of Common Stock -$4B -$7.7B -$7.6B -$2.3B -$7B
Other Financing Activities -$328M -$112M -$79M -$469M -$411M
Cash From Financing -$8.5B -$8.2B -$11.2B -$4.3B -$7.6B
 
Beginning Cash (CF) $5.4B $10.2B $5.5B $6B $8.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.8B -$4.6B $514M $2.3B $614M
Ending Cash (CF) $10.2B $5.5B $6B $8.3B $8.9B
 
Levered Free Cash Flow $9.3B $6B $7.4B $10.2B $9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.2B $1.2B $1.3B -$212M $1.4B
Depreciation & Amoritzation $715M $717M $749M $741M $674M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.4B -$399M -$407M -$2.6B -$2.4B
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $2B $5B $4.8B $1.9B
 
Capital Expenditures $242M $288M $408M $300M $327M
Cash Acquisitions -- -$57M $22M -- $2.3B
Cash From Investing -$717M -$324M -$3B -$495M $1.2B
 
Dividends Paid (Ex Special Dividend) -$345M -$357M -$368M -$401M -$412M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.3B -- $1.5B $4.5B --
Long-Term Debt Repaid -$4.2B -- -$80M -$2.2B -$700M
Repurchase of Common Stock -$2.8B -$1.4B -$962M -$4B -$1.5B
Other Financing Activities -$149M -$76M -$139M -$175M -$239M
Cash From Financing -$4.1B -$2.2B -$37M -$2.5B -$3.7B
 
Beginning Cash (CF) $10.2B $5.5B $6B $8.3B $8.9B
Foreign Exchange Rate Adjustment -$26M -$23M $5M -$9M $9M
Additions / Reductions -$3.7B -$465M $2B $1.8B -$564M
Ending Cash (CF) $6.5B $5.1B $8B $10.1B $8.4B
 
Levered Free Cash Flow $851M $1.7B $4.6B $4.5B $1.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $8.5B $5.5B $6.9B $3.9B $5.4B
Depreciation & Amoritzation $2.8B $2.9B $3B $3B $2.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.7B -$2.5B -$1.9B -$4.4B -$7.7B
Change in Inventories -- -- -- -- --
Cash From Operations $9.6B $8.1B $11.7B $11.6B $7.4B
 
Capital Expenditures $1.1B $1.2B $1.4B $1.5B $1.4B
Cash Acquisitions $5.5B -$2B $4.9B -$456M $2.7B
Cash From Investing $2.5B -$3.2B $439M -$2.7B -$410M
 
Dividends Paid (Ex Special Dividend) -$360M -$1.4B -$1.4B -$1.5B -$1.6B
Special Dividend Paid
Long-Term Debt Issued $5.7B -$2M $1.5B $4.5B --
Long-Term Debt Repaid -$9.3B -$379M -$580M -$5.1B -$1.5B
Repurchase of Common Stock -$5.9B -$6.3B -$7.2B -$5.3B -$4.5B
Other Financing Activities -$381M -$39M -$142M -$505M -$475M
Cash From Financing -$10.8B -$6.3B -$9.1B -$6.8B -$8.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.3B -$1.4B $3B $2.2B -$1.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $8.5B $6.9B $10.2B $10.2B $6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $1.2B $1.2B $1.3B -$212M $1.4B
Depreciation & Amoritzation $715M $717M $749M $741M $674M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.4B -$399M -$407M -$2.6B -$2.4B
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $2B $5B $4.8B $1.9B
 
Capital Expenditures $242M $288M $408M $300M $327M
Cash Acquisitions -- -$57M $22M -- $2.3B
Cash From Investing -$717M -$324M -$3B -$495M $1.2B
 
Dividends Paid (Ex Special Dividend) -$345M -$357M -$368M -$401M -$412M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.3B -- $1.5B $4.5B --
Long-Term Debt Repaid -$4.2B -- -$80M -$2.2B -$700M
Repurchase of Common Stock -$2.8B -$1.4B -$962M -$4B -$1.5B
Other Financing Activities -$149M -$76M -$139M -$175M -$239M
Cash From Financing -$4.1B -$2.2B -$37M -$2.5B -$3.7B
 
Beginning Cash (CF) $10.2B $5.5B $6B $8.3B $8.9B
Foreign Exchange Rate Adjustment -$26M -$23M $5M -$9M $9M
Additions / Reductions -$3.7B -$465M $2B $1.8B -$564M
Ending Cash (CF) $6.5B $5.1B $8B $10.1B $8.4B
 
Levered Free Cash Flow $851M $1.7B $4.6B $4.5B $1.6B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock